#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medullary thyroid cancer Round cell liposarcoma Pulmonary sarcoidosis Acute promyelocytic leukaemia Muscular dystrophy Epidermolysis bullosa Blastic plasmacytoid dendritic cell neoplasia CDKL5 deficiency disorder Squamous cell carcinoma of the hypopharynx Netherton's syndrome Systemic sclerosis pulmonary Familial haemophagocytic lymphohistiocytosis Cerebral amyloid angiopathy Friedreich's ataxia Vascular calcification More trials…

    Learn about Rare Diseases

    KBG syndrome – Life with Disease Loeys-Dietz syndrome – Basic Information Vascular malformation Indolent systemic mastocytosis – Life with Disease Congenital nephrogenic diabetes insipidus – Trials in Disease Nephroblastoma – Basic Information Andersen-Tawil syndrome – Treatment Shprintzen-Goldberg syndrome – Life with Disease Marginal zone lymphoma refractory – Basic Information Cerebral arteriovenous malformation haemorrhagic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Guselkumab ARI0008 Procarbazine Riboflavin Sodium Phosphate Loperamide ETX-19477 Fostemsavir Trometamol Sepiapterin COBALAMIN Meclofenamate Sodium Mosunetuzumab Vibegron TUVATEXIB Metyrapone Gilteritinib Serine EGANELISIB Sorafenib Tosilate Ambrisentan AZD6234 More therapies…

    Learn about Your Condition

    T-cell lymphoma Appendicitis perforated T-cell type acute leukaemia Hereditary optic atrophy Hodgkin's disease refractory Milk allergy Ataxia telangiectasia Hypopituitarism Aortic valve stenosis Pulmonary embolism Subarachnoid haemorrhage Fibrosarcoma Leiomyosarcoma metastatic Factor VIII deficiency Pleural mesothelioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on EXL01 with Nivolumab and FOLFOX for First-Line Treatment in Patients with PD-L1 CPS ≥5 Metastatic Gastric Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Exl01
    • Fluorouracil Sodium
    France

  • Study on the Safety and Effects of Vosilasarm Alone and in Combination for Patients with Relapsed Advanced or Metastatic Breast Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Vosilasarm
    • Elacestrant
    Spain

  • Study on Patiromer for Improving RAAS Treatment in Patients with Chronic Kidney Disease Stages 3b/4

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Hydrochlorothiazide
    • Irbesartan
    The Netherlands

  • Study on Apixaban and Edoxaban for Preventing Stroke in Patients with Recent Perioperative Atrial Fibrillation After Noncardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    • Haemorrhage
    • Atrial fibrillation
    Investigated Drugs:
    • Dabigatran
    • Edoxaban
    • Rivaroxaban
    Belgium Denmark Finland France Germany Greece +5

  • Study Comparing Standard and Adjusted Doses of Alectinib for Patients with ALK Positive Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Alectinib
    France The Netherlands

  • Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Myeloid leukaemia
    • Chronic myeloid leukaemia
    • Acute leukaemia
    Investigated Drugs:
    • Ponatinib
    Belgium France Italy The Netherlands Spain Sweden
Previous Page
1 … 429 430 431 432 433 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!